← Back to Search

Home-Based Cardiac Rehabilitation for Thoracic Cancers

N/A
Recruiting
Led By Shahed Badiyan, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
ECOG performance status ≤ 2
Planning to receive neo-adjuvant, adjuvant, or definitive radiation therapy to the thorax with curative intent.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of cardiac rehabilitation for all patients enrolled (estimated to be 36 months)
Awards & highlights

Study Summary

This trial will test the feasibility of a home-based, aerobic exercise intervention in patients with thoracic cancer at high risk for RIHD.

Who is the study for?
Adults with certain thoracic cancers like lung, esophageal, and various lymphomas who are set to receive radiation therapy. They must be able to walk, use a smartphone app for remote monitoring, and not have distant metastatic disease or other severe health issues that would prevent participation in home-based cardiac rehab.Check my eligibility
What is being tested?
The trial is testing if a home-based cardiac rehabilitation program can help reduce the negative effects on the heart from radiation therapy given for thoracic cancers. Participants will exercise at home and be monitored through an app.See study design
What are the potential side effects?
Since this trial involves aerobic exercise as part of cardiac rehabilitation, potential side effects may include muscle soreness, fatigue, and shortness of breath during physical activity. However, these are common reactions to starting an exercise regimen.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can take care of myself but might not be able to do heavy physical work.
Select...
I am scheduled for radiation therapy to my chest area to try to cure my cancer.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of cardiac rehabilitation for all patients enrolled (estimated to be 36 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of cardiac rehabilitation for all patients enrolled (estimated to be 36 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of completing home-based CR after definitive radiation therapy in patients with thoracic cancer who have started the CR program
Secondary outcome measures
Feasibility of home-based cardiac rehabiliation in all enrolled patients after definitive radiation therapy in patients with thoracic cancer.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Home-based cardiac rehabilitationExperimental Treatment1 Intervention
The intervention consists of a prescribed course of home-based cardiac rehabilitation: 36 sessions, three times a week, one hour each, over a period of 12 weeks. Each customized exercise session includes three phases: a 5- to 10-minute warm-up which consists of stretching, flexibility movements, and aerobic activity which gradually raises the heart rate to the desired level a conditioning or training phase, which consists of 20 to 45 minutes of continuous or discontinuous aerobic activity a cool down for 5 to 10 minutes consisting of low-intensity exercise that permits a gradual recovery from the conditioning phase The patient will complete a brief questionnaire on the teleHeart application after completing each exercise session on how well they tolerated the exercise. The patient's CR team will receive daily updates from the patient's teleHeart application. Based on feedback from the application, the CR team may modify the patient's exercise program going forward.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Home-based cardiac rehabilitation
2013
N/A
~40

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,937 Previous Clinical Trials
2,299,731 Total Patients Enrolled
The Foundation for Barnes-Jewish HospitalOTHER
37 Previous Clinical Trials
6,756 Total Patients Enrolled
Shahed Badiyan, M.D.Principal InvestigatorWashington University School of Medicine
2 Previous Clinical Trials
92 Total Patients Enrolled

Media Library

Home-based cardiac rehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT04072393 — N/A
Lung Cancer Research Study Groups: Home-based cardiac rehabilitation
Lung Cancer Clinical Trial 2023: Home-based cardiac rehabilitation Highlights & Side Effects. Trial Name: NCT04072393 — N/A
Home-based cardiac rehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04072393 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is the scope of this trial expanded by participant inclusion?

"Affirmative. Clinicaltrials.gov confirms that this trial, which was published on the 15th of January 2021, is actively seeking volunteers. Currently they are looking for a total of 20 participants to be recruited from one location."

Answered by AI

Are volunteers still being accepted for this research endeavor?

"According to data on clinicaltrials.gov, this experiment is actively seeking participants as of August 9th 2022 and was initially made available on January 15th 2021."

Answered by AI
~5 spots leftby Mar 2025